Ricciuti, B., Baglivo, S., Paglialunga, L., De Giglio, A., Bellezza, G., Chiari, R., . . . Metro, G. (2017). Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: Rationale, evidence and place in therapy. Ther Adv Med Oncol.

Ricciuti, Biagio, Sara Baglivo, Luca Paglialunga, Andrea De Giglio, Guido Bellezza, Rita Chiari, Lucio Crinò, und Giulio Metro. "Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-positive Non-small Cell Lung Cancer: Rationale, Evidence and Place in Therapy." Ther Adv Med Oncol 2017.

Ricciuti, Biagio, et al. "Osimertinib in Patients With Advanced Epidermal Growth Factor Receptor T790M Mutation-positive Non-small Cell Lung Cancer: Rationale, Evidence and Place in Therapy." Ther Adv Med Oncol 2017.